Learn how Wegovy® (semaglutide) can help adults with obesity or excess weight with weight related conditions. Read Important Safety and Prescribing Info, including Boxed Warning.

Jul 26, 2024 · Wegovy (semaglutide) is a prescription injection that’s used for weight loss in certain adults and children. Wegovy is only available as a brand-name drug. It doesn’t come in a generic version.

Aug 1, 2024 · Wegovy helps with long-term weight loss by regulating your body’s appetite and the amount of calories you consume. To learn more about using Wegovy for weight loss, see this article.

Mar 10, 2024 · After one year, adults taking Wegovy lost 15% of their weight (35 lb /15.9 kg) on average, compared to a 2.5% weight loss (6 lbs/2.7 kg) in those taking an inactive pill. Overall, after 68 weeks, 83% of adults taking Wegovy lost 5% or more of their weight compared to 31% of adults taking a placebo.

Sep 9, 2024 · How long do you take Wegovy for weight loss? You can use Wegovy (semaglutide) as long as needed for weight loss. This is if your doctor agrees it’s safe for you and you’re able to tolerate...

For adults with obesity or some adults with overweight and weight-related medical problems, along with a reduced calorie diet and increased physical activity. If you've struggled with your weight in the past, Wegovy® may help you lose weight and keep it off.

Jan 16, 2025 · Wegovy is used to help weight loss and maintain weight loss long-term in patients with obesity or who are overweight and have weight-related medical problems. Wegovy works by reducing appetite and slowing the gut down, so you eat less, which results in weight loss and helps with weight management.

Nov 12, 2024 · Wegovy (semaglutide) is a prescription drug prescribed for weight loss and to reduce the risk of serious cardiovascular problems. It helps aid weight loss by acting like a hormone in your...

Apr 3, 2024 · Wegovy works by slowing the rate at which food moves through the stomach, known as gastric emptying. This leads to changes in appetite, causing people to feel full more quickly and not feel hungry again after eating. Ultimately, this results in decreased calorie intake, promoting weight loss.

The late-stage trial of semaglutide, which it markets as Wegovy to treat obesity, showed that those who took a once-weekly dose of 7.2 milligrams lost an average of 20.7% of their weight over 72 ...